To combat the challenge of counterfeit diagnostic tests, IBM scientists have developed a method to embed security codes to authenticate diagnostic tests.
Qiagen and Hamilton will automate processing of the QuantiFeron-TB Gold Plus test, while the International Organization for Migration will adopt the assay.
The firm will manufacture its Logix Smart mycobacteria tuberculosis assay at its ISO-certified facility in Utah but will not seek FDA approval at this time, it said.
The portable, battery-operated system will be an interim solution for decentralized testing in places where power may be unreliable.
The 20-gene assay, which BioMérieux will develop on the BioFire FilmArray platform, distinguishes active TB from latent TB, viral, and bacterial infections.
At the recent CVS, the two large health systems described introducing Cepheid platforms for flu testing across rural and satellite locations.
Using a protocol developed at the University of Oxford, the researchers hope that nanopore sequencing can aid diagnosis and drug resistance profiling in remote areas.
The firm said that sales growth was impacted by immigration headwinds, severe winter weather in the US, and unfavorable order timing in Asia.
The medium has been cleared for transporting samples potentially containing flu A and tuberculosis.
The exclusive two-way licensing deal also allows Akonni to commercialize Righton's molecular diagnostic tests outside of China.